- ￥2588 - 9188
- abinScience
- France
- VK646030
- 2026年04月26日
- Human
- Hantaan virus (HTNV), Puumala virus (PUUV), Dobrava-Belgrade virus (DOBV), Seoul virus (SEOV), Andes virus (ANDV), Sin Nombre virus (SNV)
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
IgG1
- 形态：
Liquid
- 保存条件：
-20°C
- 克隆性：
单克隆
- 适应物种：
Hantaan virus (HTNV), Puumala virus (PUUV), Dobrava-Belgrade virus (DOBV), Seoul virus (SEOV), Andes virus (ANDV), Sin Nombre virus (SNV)
- 保质期：
twelve months
- 级别：
一抗
- 供应商：
武汉益普生物科技有限公司
- 宿主：
Human
- 抗体英文名：
InVivoMAb Anti-Hantaan virus Glycoprotein C/Gc Broad-Neutralizing Antibody (Iv0261)
- 规格：
100μg/1mg
| 规格： | 100μg | 产品价格： | ￥2588.0 |
|---|---|---|---|
| 规格： | 1mg | 产品价格： | ￥9188.0 |
| 产品名 | InVivoMAb Anti-Hantaan virus Glycoprotein C/Gc Broad-Neutralizing Antibody (Iv0261) |
| 货号 | VK646030 |
| 宿主 | Human |
| 种属反应性 | Hantaan virus (HTNV), Puumala virus (PUUV), Dobrava-Belgrade virus (DOBV), Seoul virus (SEOV), Andes virus (ANDV), Sin Nombre virus (SNV) |
| 克隆类型 | Monoclonal |
| 克隆号 | Iv0261 |
| Accession号 | Q89905 |
| 靶标 | Envelopment polyprotein, M polyprotein, Glycoprotein C, Gc, Glycoprotein G2, GP |
| 同种型 | IgG1 |
| 应用 | ELISA, Neutralization |
| 内毒素水平 | Please contact with the lab for this information. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 纯度 | >95% as determined by SDS-PAGE. |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS, pH 7.4. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| 说明 | For research use only. Not suitable for clinical or therapeutic use. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Neutralizing Bioassay Protocols
describe in vitro bioassays using neutralizing anti-mouse and anti-human cytokine antibodies. In general, the cytokine bioassay protocols are modified to pre-incubate the cytokine of interest with the specific neutralizing antibody prior to addition
Manipulation of Vaccinia Virus Vectors
expressed by a vaccinia recombinant is biologically and antigenically indistinguishable from the authentic glycoprotein (4 –bi7 ). Recombinants have been used to generate HIV-neutralizing antibody (4 –6 ) to immunize animals and humans (8 –10
). Partial deletion of the cytoplasmic domain of SARS-CoV S protein (SARS-CoV-St19) allowed efficient incorporation into the VSV particle that enabled the generation of a high titer of pseudotype virus. Neutralization assay with anti-SARS-CoV antibody
技术资料暂无技术资料 索取技术资料
